Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EXOSC3 antibody (AA 2-275) (Biotin)

EXOSC3 Reactivity: Human ELISA Host: Rabbit Polyclonal Biotin
Catalog No. ABIN7152286
  • Target See all EXOSC3 Antibodies
    EXOSC3 (Exosome Component 3 (EXOSC3))
    Binding Specificity
    • 5
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2-275
    Reactivity
    • 31
    • 10
    • 7
    • 7
    • 7
    • 7
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Host
    • 24
    • 7
    Rabbit
    Clonality
    • 26
    • 5
    Polyclonal
    Conjugate
    • 22
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This EXOSC3 antibody is conjugated to Biotin
    Application
    • 20
    • 8
    • 8
    • 5
    • 5
    • 3
    • 1
    • 1
    ELISA
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human Exosome complex component RRP40 protein (2-275AA)
    Isotype
    IgG
    Top Product
    Discover our top product EXOSC3 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    EXOSC3 (Exosome Component 3 (EXOSC3))
    Alternative Name
    EXOSC3 (EXOSC3 Products)
    Synonyms
    PCH1B antibody, RP11-3J10.8 antibody, RRP40 antibody, Rrp40p antibody, bA3J10.7 antibody, hRrp-40 antibody, p10 antibody, 2310005D06Rik antibody, AI593501 antibody, Rrp40 antibody, im:7140537 antibody, zgc:112345 antibody, exosome component 3 antibody, exosome component 3 L homeolog antibody, EXOSC3 antibody, exosc3.L antibody, Exosc3 antibody, exosc3 antibody
    Background

    Background: Non-catalytic component of the RNA exosome complex which has 3\'->5\' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding \'pervasive\' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3\' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC3 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC9 and EXOSC5.

    Aliases: EXOSC3 antibody, RRP40 antibody, CGI-102Exosome complex component RRP40 antibody, Exosome component 3 antibody, Ribosomal RNA-processing protein 40 antibody, p10 antibody

    UniProt
    Q9NQT5
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome
You are here: